David Jacoby

Observer
DISC Type : ci

Senior Vice President Head of Clinical Development at Ultragenyx

San Rafael, California, United States

Overview

David Jacoby is the SVP, Head of Clinical Development at Ultragenyx, specializing in rare genetic diseases. In his prior role at BioMarin, he led the successful registration of Brineura and Palynziq. An MD from the University of Pennsylvania, his expertise spans biologics, gene therapy, and antisense oligonucleotides for high-unmet-need disorders.


He led the team that achieved the successful registration of Brineura, a therapy for the CLN2 form of Battens disease, a rare and fatal pediatric neurodegenerative disorder.

Personality Overview

Example Seeker

Curious

Value Driven

They often ask many questions and rely heavily on information and documentation.  They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They are generally strong communicators and are not easy to convince.

Topics They Care About

Rare Disease Therapy
His career is dedicated to developing treatments for rare genetic conditions like Batten's disease, PKU, and lysosomal storage disorders, as reflected in his work and posts.
Gene Therapy Translation
He has direct experience leading the translation of AAV gene therapy for hemophilia A into clinical trials, showing expertise in bringing advanced therapies from lab to patient.
Clinical Pipeline Strategy
In his leadership roles, he is responsible for the clinical strategy of the drug pipeline, portfolio advancement, and making critical stage-advancement decisions for new programs.

Media Appearances

David has no verified media appearances

Work History

8-2024
Senior Vice President Head of Clinical Development at Ultragenyx
3-2023 - 8-2024
Group Vice President, BioMarin Fellow at BioMarin Pharmaceutical Inc.
1-2020 - 8-2024
Fellow; Vice President Discovery Medicine at BioMarin Pharmaceutical Inc.
2-2018 - 1-2020
VP, Clinical Sciences Fellow, Head of Clinical Sciences at BioMarin Pharmaceutical Inc.
6-2016 - 2-2018
Executive Group Director, Clinical Sciences at BioMarin Pharmaceutical Inc.

Education

1984 - 1992
MD from University of Pennsylvania School of Medicine
1977 - 1981
B.A. from Swarthmore College

More Information

Social Presence :

Prographics :

Exp : 36 Location : San Rafael, California, United States Job Level : Leadership Designation : Senior Vice President Head of Clinical Development at Ultragenyx
URL has been copied!

Insights For Selling To David

During A Call Or A Meeting

DO's

  • Invite them for a social do but don’t rely solely on the relationship
  • Be prepared for a lot of questions, answer them objectively
  • Use phrases like ‘clear proof that’, ‘data shows’ etc.

DONT's

  • Don’t rely excessively on your relationship with them to win the deal
  • Don’t be too objective but make sure to pad your storytelling with data points
  • Don’t brush off any concerns, take all questions seriously

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with David is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from David

  • They are practical yet friendly, don’t expect a clear no very often.

Insights For Deal Planning

    How fast (or slow) will David move?

  • They like to analyze well and then make their decisions.
  • Can David take some risk or not?

  • They systematically evaluate all decisions and are unlikely to take many risks.

You And David

Personality Compatibility


Other Ultragenyx Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.